Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Blaise

Showing results (51-60 of 510) with videos related to

Pageof 51
Sort By:
Intensive Care Medicine|June 27, 2014
Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hourDjamel Mokart, Colombe Saillard, Antoine Sannini, et al.
Bulletin Du Cancer|October 17, 2017
[Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective]Sarah Calvin, Didier Blaise, Patrick Ben Soussan, et al.
Frontiers in Immunology|November 24, 2015
Increased NK Cell Maturation in Patients with Acute Myeloid LeukemiaAnne-Sophie Chretien, Samuel Granjeaud, Françoise Gondois-Rey, et al.
Frontiers in Medicine|April 17, 2023
Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysisWen-Hui Gao, Jia-Yan Zhu, Li-Ning Wang, et al.
Leukemia & Lymphoma|May 16, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline inductionThomas Prébet, Estelle Jean, Aurélie Autret, et al.
Bone Marrow Transplantation|October 21, 2024
Post-transplant cyclophosphamide with post-engraftment anti-thymocyte globulin reduce moderate to severe chronic graft-versus-host disease in peripheral stem cell transplantation from HLA-matched unrelated and haploidentical donorsYing Wang, Wen-Hui Gao, Li-Ning Wang, et al.
Hematological Oncology|December 5, 2013
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphomaSylvain Garciaz, Diane Coso, Frederic Peyrade, et al.
Bone Marrow Transplantation|April 29, 2018
Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortalityColombe Saillard, Michael Darmon, Magali Bisbal, et al.
Cancer|November 28, 2019
Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-CalmettesLing Wang, Raynier Devillier, Ming Wan, et al.
Pageof 51

Showing results (51-60 of 510) with videos related to

Sort By:
Pageof 51
Intensive Care Medicine|June 27, 2014
Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hourDjamel Mokart, Colombe Saillard, Antoine Sannini, et al.
Bulletin Du Cancer|October 17, 2017
[Sport coaching for psychological and social recovery after hematological cancer: An innovative perspective]Sarah Calvin, Didier Blaise, Patrick Ben Soussan, et al.
Frontiers in Immunology|November 24, 2015
Increased NK Cell Maturation in Patients with Acute Myeloid LeukemiaAnne-Sophie Chretien, Samuel Granjeaud, Françoise Gondois-Rey, et al.
Frontiers in Medicine|April 17, 2023
Post-transplantation cyclophosphamide combined with tacrolimus and low-dose post-engraftment anti-thymoglobulin as GVHD prophylaxis for patients undergoing peripheral blood stem cell transplantation from haploidentical family donor: A single center analysisWen-Hui Gao, Jia-Yan Zhu, Li-Ning Wang, et al.
Leukemia & Lymphoma|May 16, 2012
Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline inductionThomas Prébet, Estelle Jean, Aurélie Autret, et al.
Bone Marrow Transplantation|October 21, 2024
Post-transplant cyclophosphamide with post-engraftment anti-thymocyte globulin reduce moderate to severe chronic graft-versus-host disease in peripheral stem cell transplantation from HLA-matched unrelated and haploidentical donorsYing Wang, Wen-Hui Gao, Li-Ning Wang, et al.
Hematological Oncology|December 5, 2013
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphomaSylvain Garciaz, Diane Coso, Frederic Peyrade, et al.
Bone Marrow Transplantation|April 29, 2018
Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortalityColombe Saillard, Michael Darmon, Magali Bisbal, et al.
Cancer|November 28, 2019
Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
Bone Marrow Transplantation|August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-CalmettesLing Wang, Raynier Devillier, Ming Wan, et al.
Pageof 51